Although cardiomyocyte (CM) apoptosis has been well described in both in vitro and in vivo models of ischemic heart disease, the intracellular pathways leading to CM death have not been fully characterized. To define the role of death receptor signaling in CM apoptosis, we constructed recombinant adenoviral vectors carrying wild-type (wt) or dominant negative (dn) forms of the death receptor adaptor protein FADD (Fas-associated death domain protein) and used these vectors to transduce rat neonatal CMs in models of hypoxia-and serum deprivation (SD)-induced apoptosis. The combination of SD and hypoxia induced rapid activation of caspase-3 and -8 as well as DNA fragmentation, reaching a plateau within 4 -8 h. Adenoviral expression of FADD-dn inhibited caspase-8 activation as well as hypoxia/SD-induced apoptosis at 24 h in an moi (multiplicity of infection)-dependent manner. In contrast, adenoviral expression of FADD-wt increased apoptosis and caspase-3 activity in CMs under both normoxic and hypoxic conditions. Surprisingly, FADD-dn, as well as the specific caspase-8 inhibitor benzyloxycarbonyl-IETD-fluoromethylketone also inhibited the activation of caspase-9 and -3 in CMs subjected to hypoxia/SD. These data suggest a primary role for FADD/caspase-8 signaling that is necessary and sufficient for apoptosis of CMs subjected to hypoxia/SD.
Cardiomyocyte loss through programmed cell death or apoptosis may contribute to overall cardiac dysfunction in a wide range of clinical settings, including ischemic heart disease (1) (2) (3) . For this reason, understanding the pathways that lead to cardiomyocyte apoptosis and identifying strategies to modulate this process may have important clinical implications.
Programmed cell death or apoptosis is a tightly regulated, organized, and energy-dependent cellular process characterized by nuclear and DNA fragmentation and condensation, membrane blebbing, and cellular shrinkage (4 -6) . Although a fully comprehensive model of apoptosis has not yet been assembled, two general pathways have been delineated (7, 8) . In the intrinsic or mitochondrial pathway, apoptosis occurs when specific stimuli lead to mitochondrial release of cytochrome c, usually in association with alterations of mitochondrial membrane potential (8) . Cytochrome c binds Apaf-1 in the cytosol and induces its oligomerization and the subsequent recruitment of pro-caspase-9. This culminates in the activation of caspase-9, which, in turn, cleaves and activates caspase-3. The pathways leading to the mitochondrial release of cytochrome c are not fully understood, although it classically occurs in cells deprived of specific growth factors or critical metabolic substrates (8) .
In the extrinsic or death receptor (DR) 1 (e.g. TNFR60, Fas/ Apo1, or TRAIL-R/Apo2) pathway, ligand binding to DR leads to the recruitment and activation of caspase-8 through specific adaptor molecules such as the Fas-associated death domain protein (FADD) (9) . Deletion of the N-terminal "death effector domain" of FADD creates a dominant negative (FADD-dn) that binds the cytoplasmic domains of DR but cannot activate caspase-8 (10) . The ability of FADD-dn to block apoptosis provides presumptive evidence for the involvement of cell death receptors (9, 10) . DRs appear to play a role not only after classic ligand-induced receptor activation but also in other settings such as UV irradiation, chemotherapy, or cell detachment, where ligand-independent DR activation can occur (11) (12) (13) (14) . DR and FADD activation of caspase-8 leads to cleavage and activation of the effector, caspase-3, and cell death. The two pathways co-exist in many circumstances. For example, activated caspase-8 can cleave and activate the pro-apoptotic Bcl-family member, Bid (15) . Cleaved Bid then inserts into the mitochondrial membrane, inducing changes in membrane potential and the release of cytochrome c (15, 16, 18) . In some settings, this amplification of DR signaling via cytochrome c release is important to the overall level of apoptosis produced (15) .
Several lines of evidence have suggested a role for the mitochondrial pathway in hypoxia and serum deprivation (SD)-induced cardiomyocyte (CM) apoptosis. In the neonatal rat CM, SD or hypoxia in the absence of glucose lead to CM apoptosis and cytochrome c release (19, 20) . In the adult rat CM, reoxygenation after hypoxia leads to caspase-3 and -9 activation, cytochrome c release, and apoptotic cell death (21) . Bcl 2 seems to play an important role in regulating cytochrome c release and caspase activation in response to hypoxia and reoxygen-ation in the adult CM (21) . These results are consistent with recent studies in fibroblasts suggesting that oxygen and glucose deprivation induce fibroblast apoptosis primarily through a decrease in mitochondrial membrane potential, leading to the release of cytochrome c and caspase-9 activation (22) .
However, other studies suggest a role for DR signaling in CM apoptosis. Fas and Fas-L are constitutively expressed in CM (23, 24) , but their expression is enhanced in CMs by hypoxia (23, 25) . Moreover, ischemia-reperfusion injury (IRI) in vivo induces the release of soluble Fas-L, sTNF␣, and TRAIL (25) . Fas-L, TRAIL, and TNF-␣ induce significant CM death under hypoxic but not normoxic conditions and in a cycloheximidedependent manner (25) . In an isolated Langendorff perfused rat heart model, reperfusion induces the activation of caspase-8 and the cleavage of Bid (26) . Moreover, in a similar model, hearts from lpr mice that lack functional Fas demonstrated a marked reduction in cell death after IRI compared with wildtype controls (25) . However, possible developmental confounders or compensatory alterations in these mutant mice are difficult to exclude. Moreover, others have questioned the relevance of Fas-mediated CM apoptosis, because an agonistic anti-Fas antibody administered systemically promotes hepatocyte but not CM apoptosis (24) .
In the present study, we explored the mechanisms of CM apoptosis induced by hypoxia and SD in vitro. Hypoxia/SD induced rapid activation of caspase-8 and -3 as well as CM apoptosis. To examine the functional contribution of DR signaling and caspase-8 activation in this model, we constructed recombinant adenoviral vectors (Ad) carrying wild-type (wt) and dominant negative forms of FADD. Our results with these genetic manipulations as well as the pharmacological inhibition of caspase-8 suggest a surprisingly important contribution of FADD/caspase-8 signaling to apoptosis of CM subjected to hypoxia/SD.
EXPERIMENTAL PROCEDURES
Materials-The neonatal cardiomyocyte isolation system was from Worthington. The caspase inhibitor benzyloxycarbonyl-Val-Ala-Aspfluoromethylketone (zVAD-fmk) was purchased from Enzyme Systems Products (Livermore, CA) and zIETD-fmk from R&D Systems. All other protease inhibitors were purchased from Calbiochem. Polyclonal caspase-3 antibodies were from Cell Signaling (Beverly, MA). Anti-FADD (H-181) was obtained from Santa Cruz Biotechnology. ␤-actin antibody was from Sigma. A cell death detection ELISA kit was purchased from Roche Molecular Biochemicals. Caspase-8, -9, and -3 activity assay kits were from R&D Systems.
In Vitro Model of Neonatal Rat Cardiomyocyte Apoptosis-CMs were prepared from 1-2 day-old rats by digestion using trypsin and collagenase as described previously (27) . All CMs were incubated in RPMI 1640 containing 5% fetal bovine serum, 10% horse serum, and 0.2% D-glucose. CMs were used for viral infection or treatment 3-4 days after plating. Unless specified, all hypoxia treatments consisted of 95% N 2 balanced with 5% CO 2 in serum-free RPMI 1640 in an air-tight humidified chamber at 37°C as described previously (27) .
Assays for Apoptosis-For DNA laddering, 1.5 g of genomic DNA fragments were 32 P-labeled by Klenow DNA polymerase and separated in agarose gel as described previously (27) . Histone-associated DNA fragments were quantified by cell death detection ELISA as described in the manufacturer's protocol. DNA fragmentation data were corrected for background and normalized to the result with normoxic cardiomyocytes.
Immunoblotting-Cultured CMs were scraped and washed once with phosphate-buffered saline. Cell suspension was then spun down, and cell pellets were lysed for 30 min in Nonidet P-40 buffer (50 mM TrisHCl, pH 7.4, 1% Nonidet P-40, 0.1% sodium deoxycholate, 15 mM NaCl, 1 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, 1 g/ml aprotinin, leupeptin, and pepstatin) and spun down 14,000 rpm for 10 min in an Eppendorf tube as described previously. Proteins were then separated in 4 -12% gradient SDS-PAGE and transferred to nitrocellulose membranes. Nonspecific protein binding was blocked in blocking buffer (5% milk, 20 mM Tris-HCl, pH 7.6, 150 mM NaCl, and 0.1% Tween 20) and blotted with specific antibodies as indicated for each experiment in the blocking buffer at 4°C overnight. For repeated blotting, nitrocellulose membranes were stripped with Restore Western blot stripping buffer (Pierce) at room temperature for 30 min.
Caspase Activity Assay-Caspase-3, -8, and -9 activity was examined by using the caspase colorimetric assay kit from R&D Systems according to the manufacturer's protocol. Briefly, cells were scraped and transferred to 15-ml tubes. The cell suspension was centrifuged and washed once with cold phosphate-buffered saline. The cell pellets were then lysed in 120 l of cold lysis buffer. Cell lysates (150 -250 g of protein) were incubated on ice for 10 min and centrifuged at 10,000 ϫ g for 1 min. The supernatants were removed and assayed for caspase activity. The specific peptide substrates used for each individual caspase were DEAD-pNA, LEHD-pNA, and IETD-pNA for caspase-3, -9, and -8, respectively. Release of the pNA cleavage product was quantitated in a microplate reader (Bio-Rad) at a wavelength of 405 nm.
Recombinant Adenoviral Vectors-Four replication-deficient recombinant Ad vectors were employed in the present study. Ad.FADD-wt and Ad.FADD-dn carry separate CMV-driven expression cassettes for FADD and GFP and were constructed by subcloning the cDNA for human FADD-wt and FADD-dn (kindly provided by Dr. Vishva Dixit, University of Michigan and Genentech) into pAdTrackCMV and obtaining homologous recombinants through co-transformation with pAdEasy-1 in Escherichia coli BJ 5183 cells as described previously (28) . Ad.IGF-I carries separate CMV-driven expression cassettes for insulin-like growth factor I (IGF-I) and the GFP and was constructed by subcloning the cDNA for human IGF-IB (kindly provided by Dr. P. S. Rotwein) as described above for Ad.FADD. Ad.GFP is structurally similar to Ad.IGF-I but encodes the GFP only. Viral titer was determined by plaque assay in 293 cells. Stock titers were Ͼ10 10 plaque-forming units (pfu)/ml for each vector with a particle/pfu ratio of 10 -100. Wildtype adenovirus contamination was excluded by the absence of PCRdetectable E1 sequences.
Statistical Analysis-All data were expressed as the mean Ϯ S.D. of at least three independent experiments and evaluated with a twotailed, unpaired Student's t test. The null hypothesis was rejected for p Ͻ 0.05.
RESULTS
Hypoxia and SD Induce DNA Fragmentation and the Rapid Activation of Caspase-3 and -8 -The combination of hypoxia and SD induced a time-dependent cleavage of 35-kDa pro-caspase-3 with the appearance of the 19-kDa active form of caspase-3 (Fig. 1A) . The processing of pro-caspase-3 to caspase-3 occurred early, within 2 h of hypoxia/SD, and reached its maximal level within 4 h. The time course of pro-caspase-3 cleavage in response to hypoxia/SD corresponded well with measured caspase-3 activity, which also plateaued within 4 h (Fig. 1B) . To delineate the individual contribution of serum deprivation and hypoxia to CM apoptosis, CMs were subjected to hypoxia and SD alone or in combination. As shown in Fig. 1 , C and D, within 4 h of SD there was significant DNA laddering as well as caspase-3 cleavage and activation even in the absence of hypoxia. The combination of hypoxia and SD modestly increased the level of caspase-3 activation (Fig. 1D) and DNA laddering at 4 h (Fig. 1C) compared with SD alone. In the presence of serum, hypoxia for up to 24 h failed to induce caspase-3 activation and DNA fragmentation (Fig. 1, C and D) . These results suggest that neonatal cardiomyocytes are much more sensitive to serum deprivation than to hypoxia. To define the functional importance of caspase activation in hypoxia/SDinduced CM apoptosis, we examined the effect of the general caspase inhibitor, zVAD-fmk, on hypoxia/SD-induced DNA fragmentation. The treatment of CMs with zVAD-fmk at concentrations ranging from 50 -100 M inhibited hypoxia/ SD-induced apoptosis as evidenced by ELISA for histoneassociated DNA fragmentation ( Fig. 2A ) and DNA laddering (Fig. 2B) , confirming the functional importance of caspase activation in this model.
To explore the role of DR signaling in hypoxia/SD-induced CM apoptosis, we examined the activity of the apical DR caspase, caspase-8. Hypoxia/SD induced a time-dependent in-crease in caspase-8 activity that reached a maximal level within 4 h (Fig. 3) . These data suggested that caspase-8 activation also occurs early in hypoxia/SD and could contribute to caspase-3 activation and the overall apoptosis observed.
FADD-dn Inhibits Hypoxia/SD-induced CM Apoptosis-To delineate the functional contribution of DR signaling in this model, we constructed recombinant Ad vectors carrying the wild-type and dominant negative forms of FADD and used these vectors to transduce rat neonatal CMs subjected to hypoxia/SD. As shown in Fig. 4A , adenoviral gene transfer induced dose-dependent expression of the FADD-dn protein in CM (Fig. 4A) . Hypoxia and SD induced up to a 3.8-fold increase in DNA fragmentation within 24 h in CMs infected with control virus. Adenoviral expression of FADD-dn but not FADD-wt dramatically reduced the apoptotic effect of hypoxia/SD as demonstrated by histone-DNA fragmentation ELISA and DNA laddering (Fig. 4) . Similarly, adenoviral expression of IGF-I, which has a known cardioprotective effect, also inhibited DNA laddering in CM (Fig. 4C) . The anti-apoptotic effect of FADD-dn in CMs was moi-dependent as demonstrated by DNA laddering (24-h hypoxia) (Fig. 4D) . To confirm these results, we employed a specific caspase-8 inhibitor, zIETD-fmk. Both the activation of caspase-8 and CM apoptosis in response to 4 h hypoxia/SD were also completely inhibited by zIETD-fmk (Fig.  4E) . Together, these data suggest that FADD signaling to caspase-8 is necessary for hypoxia/SD-induced CM apoptosis.
In contrast, the overexpression of FADD-wt induced significant DNA fragmentation even under normoxic conditions in the presence of serum (Fig. 4F) . Hypoxia/SD did not further enhance DNA fragmentation induced by FADD-wt overexpression (Fig. 4F) . These results establish that FADD is necessary for hypoxia/SD-induced activation of caspase-8 as well as CM apoptosis and is sufficient for CM apoptosis.
FADD-dn Inhibits Caspase-3 Activation Induced by Hypoxia and Serum Deprivation-We were surprised by the degree of protection afforded by the inhibition of FADD/caspase-8 and therefore examined whether these interventions were sufficient to inhibit caspase-3 activation. As shown in Fig. 5 , in the presence of serum and normoxia there was minimal activation of caspase-3 in uninfected control cells. Neither Ad.GFP nor Ad.FADD-dn infection significantly affected caspase-3 activity at baseline. However, hypoxia/SD induced significant activation of caspase-3 (up to 3-fold) in both uninfected and Ad.GFPinfected CMs. Importantly, adenoviral expression of FADD-dn significantly inhibited the processing and activation of caspase-3 (Fig. 5) . Moreover, consistent with its effect on DNA fragmentation, the overexpression of FADD-wt resulted in a significant increase in caspase-3 activity, although the processing of pro-caspase-3 was not evident by immunoblotting, most likely reflecting the greater sensitivity of the enzymatic assay (Fig. 5) .
Effect of Adenoviral Expression of FADD and Caspase-8
Inhibitor on Caspase-8 and Caspase-9 -Because the intrinsic mitochondrial pathway appears to play a primary role in some models of hypoxia-induced apoptosis (22), we were surprised that this pathway did not induce more robust CM apoptosis even in the face of FADD inhibition. Therefore, we examined the activation of caspase-9, the apical caspase in the mitochondrial pathway, in CMs subjected to hypoxia/SD as well as the effects of FADD-dn overexpression or zIETD-fmk treatment. As expected, both zIETD-fmk (Fig. 4E ) and the overexpression of FADD-dn (Fig. 6A) effectively blocked hypoxia/SD-induced caspase-8 activation in CMs. Surprisingly, the activation of caspase-9 was also completely inhibited by pretreatment with zIETD-fmk or the overexpression of FADD-dn (Fig. 6B) . Together, these results suggest that both FADD and caspase-8 act upstream of caspase-9 and play a dominant role in CM apoptosis induced by serum deprivation and hypoxia.
DISCUSSION
Although CM apoptosis has been well documented in both in vivo and in vitro models of ischemic heart disease, the intracellular signaling mechanisms leading to CM death in these settings has not been fully defined. Several previous reports have demonstrated that the mitochondrial pathway plays a role in CM apoptosis. The present study was designed to examine the role of DR signaling in CM apoptosis through manipulation of the critical adaptor molecule FADD. We found that the combination of serum deprivation and hypoxia caused rapid activation of caspase-8, -9, and -3 as well as DNA fragmentation. Adenoviral expression of FADD-dn as well as treatment with the specific caspase-8 inhibitor zI-ETD-fmk dramatically inhibited CM apoptosis and the activation of caspase-8,-9, and -3. In contrast, the expression of wild-type FADD induced caspase-3 activation and CM apoptosis. Together, these data demonstrate an important role for FADD signaling in the early caspase activation induced by hypoxia/SD in CM and suggest that in this system FADDmediated activation of caspase-8 occurs upstream of caspase-9 activation.
Our work is consistent with prior studies demonstrating the general importance of caspases in cardiomyocyte apoptosis in both in vivo and in vitro models of ischemia (19 -21, 26, 29, 30) . Consistent with the previous studies, serum-deprivation but not hypoxia alone caused rapid activation of caspase-9 and -3 in cultured neonatal rat CM, and the general caspase inhibitor zVAD-fmk prevented CM apoptosis. To our knowledge, however, our data are the first to demonstrate that hypoxia/SDinduced activation of caspase-9 and -3 occurs downstream of FADD and caspase-8 activation in CMs and that FADD signaling is both necessary and sufficient for CM apoptosis in this setting. However, precedent exists for a critical role of caspase-8 in hypoxia-induced apoptosis in other systems. For example, in Jurkat cells hypoxia induces apoptotic cell death that can be effectively inhibited by overexpression of the caspase-8 inhibitor v-FLIP (31) .
Our studies contrast with work (22) in fibroblasts demonstrating a primary role for the mitochondrial pathway in hypoxia-mediated apoptosis. These differences may reflect important differences between the cells being studied and/or the specifics of the experimental conditions employed. For example, McClintock et al. (22) found that an activated mutant of the serine/threonine kinase Akt was not able to protect fibroblasts from apoptosis after hypoxia (22) . In contrast, we have demonstrated that Akt can protect CM from hypoxia-induced apoptosis in vitro (27) and ischemia reperfusion-induced apoptosis in vivo (32) . Thus, the signaling pathways controlling cell death may function differently in these cell types. However, the precise conditions utilized may also be critical. McClintock et al. (22) found that the intrinsic pathway was most powerfully activated by the combination of hypoxia and glucose deprivation. In the current study as well as in a study by Malhotra Expression of FADD-dn was examined by Western blotting using a polyclonal anti-FADD antibody. B, time course of hypoxia/SD-induced DNA fragmentation. Cells were infected with control virus, Ad.GFP, or Ad.FADD-dn overnight followed by serum-deprivation and hypoxia for the indicated period. DNA fragmentation was quantitated using an ELISA for histone-associated DNA fragments and expressed as -fold increase over normoxic Ad.GFP-infected cells. Each time point represents the mean Ϯ S.D. of four independent experiments. *, p Ͻ 0.01. C, Ad.FADD-dn and Ad.IGF-I but not Ad.FADD-wt inhibits DNA fragmentation. Cells were infected with the indicated adenoviral construct overnight in regular medium before being washed and incubated in serum-free medium (SD) in the presence or absence of hypoxia. Genomic DNA was extracted, radiolabeled, and subjected to size fractionation by gel electrophoresis. D, Ad.FADD-dn inhibits hypoxia/SD-induced DNA fragmentation in an moi-dependent manner. Cells infected with Ad.GFP or Ad.FADD-dn at the indicated moi were exposed to hypoxia/SD for 24 h before an analysis of DNA laddering by gel electrophoresis as above. E, zIETD-fmk inhibits hypoxia/SD-induced activation of caspase-8 and DNA-fragmentation. Cells were either left untreated or treated with 50 M zIETD-fmk for 1 h prior to hypoxia/SD for 4 h. At the end of hypoxia/SD treatment, caspase-8 activity and DNA fragmentation were examined as described under "Experimental Procedures. these results (19, 22) , in the presence of glucose we saw no significant increase in cytochrome c release in CMs subjected to hypoxia/SD (data not shown).
Our data also provide evidence for cross-talk between these pathways in CMs, because caspase-9 activation was dependent on FADD signaling via caspase-8. However, it remains unclear how caspase-8 activation induced activation of caspase-9 because (as noted above) we did not observe a significant increase in cytochrome c release. Unfortunately, our efforts to identify Bid cleavage in this rat system using available antibody reagents have thus far been unsuccessful (data not shown), although Bid cleavage would be expected to induce caspase-9 activation through cytochrome c release, which we did not observe. Thus, the possibility that previously unappreciated connections exist between the intrinsic and extrinsic pathways of apoptosis appears worthy of further investigation (Fig. 7) . The assays utilized in this report are based on the highly stringent substrate specificities of the caspases themselves, which have been rigorously determined through use of a positional scanning combinatorial library (17) . Thus, the possibility that other caspases contribute to the specific activity measurements presented in the current study appears unlikely but difficult to completely exclude. Moreover, these considerations would not alter the central conclusion of the present study as to the surprising importance of DR/FADD signaling in hypoxia/ SD-induced CM apoptosis.
Other limitations of this study should also be acknowledged. We did not identify which death receptor is involved in signaling via FADD. Although the Fas/Fas-L system is a reasonable candidate because it is expressed in CM and induced by hypoxia (23, 25) , multiple receptors (e.g. TNFR60, Fas/Apo1, or TRAIL-R/Apo2) can signal through FADD and can, under some circumstances, do so in a ligand-independent manner (11) (12) (13) (14) . Thus, defining the functional importance of these various upstream pathways will be a complex but valuable undertaking. Finally, we have also focused on a simple in vitro model of apoptosis induced by hypoxia/SD in rat neonatal CM. The relevance of these findings to the adult CM in an intact heart remains to be demonstrated. The vectors described in this study should provide valuable tools for such an investigation.
In conclusion, the present study demonstrates that FADD signaling via caspase-8 is necessary for hypoxia/SD-induced CM apoptosis and is sufficient for apoptosis of normoxic CM. Delineation of the intracellular signaling pathways leading to CM apoptosis in different settings may lead to novel therapeutic approaches in ischemic or other heart disease.
